Physician

John J Mazur, M.D.

According to 2025 Medicare claims, John Mazur, M.D. (NPI: 1659364651) practices pulmonary disease in the Great Falls, MT market, with the plurality of this provider's patient population coming from Cascade, MT. This provider's primary affiliated billing organization is GREAT FALLS CLINIC LLC (NPI: 1801897780; TIN: 841396628) and primary practice location at 59405-5240. Mazur is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and PRIVIA QUALITY NETWORK - I LLC (ACO ID: A5533), participating under the MSSP model.

Mazur's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 4,075 HCPCS/CPT codes, and received $218,979 in Medicare payments. The top billing code was 90677 (Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use). Part D data shows 3,020 prescription claims across 360 beneficiaries totaling $2,115,982 in drug costs, led by Opsumit (Macitentan). DME data shows 2,723 claims. Open Payments data shows 47 records totaling $1,159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $219,255 to $218,979. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $734,730 to $2,115,982. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $188,127 and ending at $161,013.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	498	4,250	$219,255
2016	473	3,485	$158,342
2017	479	3,720	$170,417
2018	499	3,832	$178,950
2019	545	3,485	$179,923
2020	461	5,535	$202,133
2021	513	8,225	$313,920
2022	513	6,866	$265,290
2023	520	6,644	$291,396
2024	372	4,075	$218,979

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	206	2,054	$734,730
2016	224	2,318	$1,048,512
2017	265	2,388	$1,695,380
2018	286	2,638	$1,923,220
2019	307	2,626	$1,932,746
2020	294	2,658	$2,417,702
2021	329	2,804	$1,695,742
2022	356	2,928	$1,770,046
2023	358	3,176	$1,992,665
2024	360	3,020	$2,115,982

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	505	2,499	$232,069
2016	437	2,481	$175,188
2017	533	2,504	$133,886
2018	703	3,067	$197,791
2019	673	2,982	$220,827
2020	610	2,586	$222,615
2021	714	2,806	$242,265
2022	695	2,760	$223,876
2023	650	2,937	$244,258
2024	659	2,723	$186,279

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90677	Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use	74	75	$289
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	320	611	$90
G0009	Administration of pneumococcal vaccine	74	75	$32
94060	Test to measure expiratory airflow and volume changes before and after medication administration	175	231	$28
94010	Test to measure expiratory airflow and volume	245	367	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Opsumit	Macitentan	46	1,380	$584,329
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	299	12,900	$269,913
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	226	8,913	$138,606
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	160	5,850	$115,157
Breo Ellipta	Fluticasone/Vilanterol	142	6,510	$81,760

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	99	786	$72,698
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	25	$20,403
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	19	$16,947
A7030	Full face mask used with positive airway pressure device, each	N	48	117	$10,133
A7031	Face mask interface, replacement for full face mask, each	N	46	164	$9,520

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$1,159	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John J. Mazur, M.D.?

Tedicare shows public-source Medicare data for John J. Mazur, M.D. (NPI 1659364651), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John J. Mazur, M.D. have ACO affiliation data?

John J. Mazur, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and PRIVIA QUALITY NETWORK - I LLC (MSSP, ACO ID A5533).

What billing organization is linked to John J. Mazur, M.D.?

John J. Mazur, M.D. is linked to GREAT FALLS CLINIC LLC (billing NPI 1801897780) in the available physician profile data.

Does John J. Mazur, M.D. have Open Payments data?

John J. Mazur, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.